InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ENANTA PHARMACEUTICALS INC

ENTA Clue Score19
United States Fiscal year ends September CIK 0001177648 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Jay R. Luly
6 Dec 2024
President and CEO
Sold on a plan
5,142
$8.06
$41.44K
Paul J Mellett
6 Dec 2024
Chief Fin. & Admin Officer
Sold on a plan
2,591
$8.06
$20.88K
Yat Sun Or
6 Dec 2024
Chief Scientific Officer
Sold on a plan
2,591
$8.06
$20.88K
Scott T. Rottinghaus
6 Dec 2024
Chief Medical Officer
Sold on a plan
866
$8.06
$6.98K
Brendan Luu
6 Dec 2024
Chief Business Officer
Sold on a plan
2,283
$8.06
$18.40K
Tara Lynn Kieffer
6 Dec 2024
Chief Product Strategy Officer
Sold on a plan
2,283
$8.06
$18.40K
Scott T. Rottinghaus
12 Jul 2024
Chief Medical Officer
Sold on a plan
2,271
$15.04
$34.16K
Scott T. Rottinghaus
11 Jul 2024
Chief Medical Officer
Sold on a plan
4,299
$15.07
$64.79K
Tara Lynn Kieffer
17 Jun 2024
Chief Product Strategy Officer
Sold on a plan
7,266
$12.33
$89.59K
Show all 158 transactions →

What was left out

Form 4 filings counted 311
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 72
Sales at will 45
Transactions with no price 0
Shares from compensation/vesting 1,706,623
Sales filed before the plan box existed 28
History held since 22 Mar 2013